Spit test may predict withdrawal severity in Opioid-Exposed newborns
NCT ID NCT05937594
First seen Feb 02, 2026 · Last updated May 08, 2026 · Updated 11 times
Summary
This study looks at whether small molecules called microRNAs in a newborn's saliva can help doctors predict how much medicine they need for opioid withdrawal and how their brain develops later. About 50 babies born to mothers who used opioids during pregnancy will provide spit samples and have their development checked over time. The goal is to find simple biological markers that could lead to more personalized and effective care.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEONATAL ABSTINENCE SYNDROME are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Penn State Milton S. Hershey Medical Center
RECRUITINGHershey, Pennsylvania, 17033, United States
Conditions
Explore the condition pages connected to this study.